JP2024529425A5 - - Google Patents
Info
- Publication number
- JP2024529425A5 JP2024529425A5 JP2024504461A JP2024504461A JP2024529425A5 JP 2024529425 A5 JP2024529425 A5 JP 2024529425A5 JP 2024504461 A JP2024504461 A JP 2024504461A JP 2024504461 A JP2024504461 A JP 2024504461A JP 2024529425 A5 JP2024529425 A5 JP 2024529425A5
- Authority
- JP
- Japan
- Prior art keywords
- grna
- amino acid
- cas9
- adenosine deaminase
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163225322P | 2021-07-23 | 2021-07-23 | |
| US63/225,322 | 2021-07-23 | ||
| US202163255927P | 2021-10-14 | 2021-10-14 | |
| US63/255,927 | 2021-10-14 | ||
| PCT/US2022/074041 WO2023004409A1 (en) | 2021-07-23 | 2022-07-22 | Guide rnas for crispr/cas editing systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024529425A JP2024529425A (ja) | 2024-08-06 |
| JP2024529425A5 true JP2024529425A5 (enExample) | 2025-07-18 |
Family
ID=83149172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024504461A Pending JP2024529425A (ja) | 2021-07-23 | 2022-07-22 | ＣＲＩＳＰＲ／Ｃａｓ編集系のためのガイドＲＮＡ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240301405A1 (enExample) |
| EP (1) | EP4373931A1 (enExample) |
| JP (1) | JP2024529425A (enExample) |
| KR (1) | KR20240037299A (enExample) |
| AU (1) | AU2022313315A1 (enExample) |
| CA (1) | CA3226664A1 (enExample) |
| WO (1) | WO2023004409A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230383277A1 (en) * | 2020-10-14 | 2023-11-30 | Beam Therapeutics Inc. | Compositions and methods for treating glycogen storage disease type 1a |
| WO2024220980A2 (en) * | 2023-04-20 | 2024-10-24 | The Schepens Eye Research Institute, Inc. | Dscam inhibitory nucleic acids and methods of use thereof |
| JP2026523341A (ja) | 2023-05-15 | 2026-07-14 | エヌクロマ・バイオ，インコーポレーテッド | Ｈｂｖ遺伝子発現のエピジェネティック調節のための組成物および方法 |
| CN122161928A (zh) * | 2023-10-25 | 2026-06-05 | 上海尧唐生物科技股份有限公司 | 一种脱氨酶、包含其的碱基编辑器及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0825869B2 (ja) | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US5846946A (en) | 1996-06-14 | 1998-12-08 | Pasteur Merieux Serums Et Vaccins | Compositions and methods for administering Borrelia DNA |
| EP2397490B1 (en) | 2004-07-16 | 2013-09-04 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Vaccine constructs and combinations of vaccines designed to improve the breadth of the immune response to diverse strains and clades of HIV |
| JP2011512326A (ja) | 2007-12-31 | 2011-04-21 | ナノコア セラピューティクス，インコーポレイテッド | 心不全の治療用のｒｎａ干渉 |
| ES2728782T3 (es) | 2012-05-25 | 2019-10-28 | Univ California | Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN |
| CN105139759B (zh) | 2015-09-18 | 2017-10-10 | 京东方科技集团股份有限公司 | 一种拼接屏 |
| US11286480B2 (en) * | 2015-09-28 | 2022-03-29 | North Carolina State University | Methods and compositions for sequence specific antimicrobials |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| EP3829597A4 (en) * | 2018-07-30 | 2022-05-18 | Sarepta Therapeutics, Inc. | TRIMER PEPTIDES FOR ANTISENSE ADMINISTRATION |
| JP2020038883A (ja) | 2018-09-03 | 2020-03-12 | 株式会社オートネットワーク技術研究所 | 回路構造体及び回路構造体の製造方法 |
| EP4034658A4 (en) * | 2019-09-23 | 2023-11-29 | Flagship Pioneering Innovations V, Inc. | MODULATION OF GENOMIC COMPLEXES |
| EP4058032A4 (en) * | 2019-12-19 | 2024-01-10 | Entrada Therapeutics, Inc. | Compositions for delivery of antisense compounds |
-
2022
- 2022-07-22 KR KR1020247005580A patent/KR20240037299A/ko active Pending
- 2022-07-22 CA CA3226664A patent/CA3226664A1/en active Pending
- 2022-07-22 WO PCT/US2022/074041 patent/WO2023004409A1/en not_active Ceased
- 2022-07-22 JP JP2024504461A patent/JP2024529425A/ja active Pending
- 2022-07-22 AU AU2022313315A patent/AU2022313315A1/en active Pending
- 2022-07-22 EP EP22761858.4A patent/EP4373931A1/en active Pending
-
2024
- 2024-01-22 US US18/418,751 patent/US20240301405A1/en active Pending